(Q34643392)

3 August 2017

The influence of nutritional factors on the prognosis of multiple sclerosis (English)

1 reference

3 August 2017

0 references

Gloria von Geldern

1

1 reference

3 August 2017

Ellen M Mowry

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

2 October 2012

1 reference

3 August 2017

Nature Reviews Neurology

1 reference

3 August 2017

8

1 reference

3 August 2017

678-689

1 reference

3 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.194

3 August 2017

0 references

cites work

Complementary and alternative medicine for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Manipulating dendritic cells to induce regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Intervention in autoimmunity: the potential of vitamin D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin D, invariant natural killer T-cells and experimental autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Diet and the geographical distribution of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Risk factors of multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Environmental risk factors in MS: a case-control study in Moscow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The beneficial and detrimental effects of linoleic acid on autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Review of MS patient survival on a Swank low saturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

In vivo damage of CNS myelin and axons induced by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum uric acid and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Comparison of uric acid and ascorbic acid in protection against EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The treatment of multiple sclerosis with inosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Lipoic acid in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Matrix metalloproteinase inhibition by green tea catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

SIRT1 activation confers neuroprotection in experimental optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Current Complementary and Alternative Therapies for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Recent progress in ginkgolide research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The molecular basis of nutritional intervention in multiple sclerosis: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Curcumin has bright prospects for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Small-bowel abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Morphological and biochemical findings in jejunal biopsies from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Prevalence of celiac disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Frequency of celiac disease is not increased among multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Influence of dietary components on regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Treatment and management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Blood biomarkers of vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Intrathecal levels of vitamin D and IgG in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Multiple sclerosis and nutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary interventions for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum uric acid levels in patients with multiple sclerosis: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Suppression of experimental allergic encephalomyelitis by retinoic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Beneficial effects of blueberries in experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Serum cobalamin deficiency is uncommon in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

IgA antibodies against gliadin and gluten in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Multiple sclerosis and gluten sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.194

Bone health: osteoporosis, calcium and vitamin D

31 March 2020

1 reference

12 December 2020

Nutrition, latitude, and multiple sclerosis mortality: an ecologic study

1 reference

12 December 2020

Implications for 25-hydroxyvitamin D testing of public health policies about the benefits and risks of vitamin D fortification and supplementation.

1 reference

12 December 2020

Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.

1 reference

12 December 2020

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course

1 reference

12 December 2020

The distribution of multiple sclerosis in relation to the dairy industry and milk consumption

1 reference

12 December 2020

Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis

1 reference

12 December 2020

Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system

1 reference

12 December 2020

Multiple sclerosis; a correlation of its incidence with dietary fat

1 reference

12 December 2020

The control of experimental allergic encephalomyelitis with retinoic acid. Further studies

1 reference

12 December 2020

Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor

1 reference

12 December 2020

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition

1 reference

12 December 2020

Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions

1 reference

12 December 2020

Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet

1 reference

12 December 2020

Nutrition and immunity: the immunoregulatory effect of n-6 essential fatty acids is mediated through prostaglandin E.

1 reference

12 December 2020

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation

1 reference

12 December 2020

10.1038/NRNEUROL.2012.194

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference